Hurt in a Car Accident or
Motorcycle Crash? Lost a Loved
One in a Wrongful Death?
Valsartan Recall Lawyer
What is Valsartan?

Valsartan is a drug that is used to treat high blood pressure, heart failure, and certain types of diabetes. Valsartan is classified as an angiotensin receptor blocker (ARB), and is able to treat high blood pressure or heart failure by enlarging blood vessels and reducing blood pressure, which assists the heart with functioning more efficiently.
The following drugs are labeled as ARBs:
- Valsartan
- Losartan
- Irbesartan
- Azilsartan
- Olmesartan
- Eprosartan
- Telmisartan
- Candesartan
Recent lawsuits have arisen that claim Valsartan drugs may have been contaminated with potentially cancer causing impurities dating as far back as 2012.
It is important to note that not all Valsartan drugs are tainted. Patients who are currently being treated with any Valsartan medications that could have been contaminated should have received notice in or around July 2018, regarding whether the lots of Valsartan drugs involved in their treatment were part of the pending recalls. If you or someone you love was taking Valsartan drugs on the list of possibly tainted lots and have suffered any of the following injuries or side-effects, you may be entitled to financial compensation.
- Liver Cancer
- Liver Damage
- Colorectal Cancer
- Kidney Cancer
- Stomach Cancer
- Kidney Damage
- Bowel Cancer
- Pancreatic Cancer
- Lower Esophageal Cancer
- Non-Hodgkin’s Lymphoma
- Leukemia
- Multiple Myeloma
- Headaches
- Fever
- Nausea
- Vomiting
- Cramps
- Enlarged liver
- Reduced organ function
Companies with Valsartan Products Recalled by the FDA
When a medication is recalled, the medical community must monitor the dangers posed by the tainted product. In the case of Valsartan, officials recalled the drug due to a contaminant found in batches and related products that were already in use. Officials found that specific batches of Valsartan contained an impurity of N-Nitrosodimethylamine (NDMA), which the United States Environmental Protection Agency (EPA) classifies as a probable carcinogen.
The following is a list of companies with Valsartan products that were recalled by the FDA:
- American Health Packaging
- A-S Medication Solutions LLC
- Aurobindo Pharma USA, Inc
- AvKARE
- Bryant Ranch Prepack Inc
- H J Harkins Company Inc. dba Pharma Pac
- Hetero Labs, Inc. labeled as Camber Pharmaceuticals, Inc
- Major Pharmaceuticals
- Mylan Pharmaceuticals
- Northwind Pharmaceuticals
- NuCare Pharmaceuticals Inc.
- Preferred Pharmaceuticals, Inc.
- Prinston Pharmaceutical Inc. labeled as Solco Healthcare LLC
- RemedyRepack, Inc
- Rising Pharmaceuticals Inc.
- Solco Healthcare
- Teva Pharmaceuticals labeled as Major Pharmaceuticals
- Teva Pharmaceuticals USA Inc
- Teva Pharmaceuticals USA labeled as Actavis
- Torrent Pharmaceuticals Limited
Valsartan Recall Lawsuits
Across the nation, individuals have filed numerous lawsuits against companies that manufactured contaminated Valsartan drugs. The companies currently involved in litigation are Zhejiang Huahai Pharmaceutical, Prinston Pharmaceutical, Solco Healthcare, Hetero Labs, Camber Pharmaceuticals, Torrent Pharmaceuticals, Major Pharmaceutical, and Teva Pharmaceutical.
These lawsuits are seeking economic damages from purchasing the recalled drugs, personal injury damages from cancer or severe liver damage caused by the recalled drugs, and financial damages from insurers and other third parties that paid for the recalled drugs. These lawsuits allege that the companies involved in the manufacturing process knew, or should have known, that Valsartan impurities arose as early as 2012, and should have warned patients and medical professionals of the dangers. A Multi-District Litigation (MDL) now consolidates these claims to streamline pretrial activities, saving time, court costs, and attorneys’ fees. Likewise, the federal nationwide Valsartan claims are centralized in MDL 19-2875 in the United States District Court for the District of New Jersey, Camden Vicinage, under Judge Robert B. Kugler. As of October 2019, more than 100 lawsuits were pending in the MDL.
Our team at Whittel & Melton specializes in Florida Valsartan lawsuits and has extensive experience in MDL litigation. We effectively negotiate with pharmaceutical settlement representatives on behalf of our clients. We urge you to contact us right away with any questions or concerns you may have after using Valsartan.
What is NDMA?
NDMA, or N-Nitroso-dimethylamine, is classified as a probable human carcinogen, meaning it could potentially lead to cancer development based on results from laboratory tests. This chemical can alter DNA, which is why it poses a cancer risk.
Rocket fuel producers originally used NDMA, but they halted production after detecting high levels of the compound in air, water, and soil near a rocket fuel plant.
Exposure to NDMA can cause various symptoms, including headaches, fever, nausea, jaundice, vomiting, abdominal cramps, an enlarged liver, and reduced function of the liver, kidneys, and lungs, as well as dizziness.
Call Our Attorneys Whittel & Melton – 866-608-5529
We want to remind you that time is of the essence in these cases. There are time constraints called statutes of limitations that apply when filing personal injury claims.
We are here to help you understand everything related to the recalls and any pending litigation involving financial recovery.
Contact us today to learn more about your legal options. There is absolutely no cost or obligation to discuss your potential case with us.















